Axsome Therapeutics Inc (AXSM)

[Goodtime13]

Agreed. It is all about clinical development. I would add that their current MC is "deserved". What's amazing is that their MC was so low just a few months ago in light of the many proofs of concept that make successful readouts more likely than not and the sizable indications they are pursuing.

I am in on this company because of its potential indications in Treatment Resistant Depression, Alzheimer's Agitation, and Major Depression Disorder.
It is my belief that successful readouts in TRD or Alz Agitation would easily/conservatively add $3B in Market Cap and MDD another $1B - again, conservatively. I feel confident (at least 70%+ for each) that all of these will be successful.

I have no idea on the chances of success in Narcolepsy or smoking cessation but they all seem like reasonable shots on goal. I don't believe either of them to be market movers however.

If Migraine reads out positive I don't believe it to significantly create anything other than a distraction. So many generic agents and not a novel compound or MOA.